Advertisement

Topics

AZ chief Soriot bullish despite falling sales

07:53 EST 9 Nov 2017 | pharmaphorum

AstraZeneca’s CEO Pascal Soriot has described 2017 as a “defining” year for the company, with a series of new products gaining traction and the worst of a series of patent losses in the past. In a third-quarter results call, Soriot said that...

Original Article: AZ chief Soriot bullish despite falling sales

NEXT ARTICLE

More From BioPortfolio on "AZ chief Soriot bullish despite falling sales"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...